AI-driven healthcare solutions provider Tempus AI (TEM) has disclosed acquisition of Deep 6 AI, a precision research platform ...

The new general AI agent from China had some system crashes and server overload—but it’s highly intuitive and shows real ...

Tempus AI (TEM) announced it has acquired Deep 6 AI. Deep 6 AI enables healthcare organizations to de-risk clinical trials, accelerate ...

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) saw unusually-strong trading volume on Tuesday after Needham & Company LLC raised their price target on the stock from $56.00 to $70.00.

It’s been a rocky few days for Tempus AI (NASDAQ:TEM). After hitting a high of $91.45, the stock plummeted to a low of $55.20. All thanks to an earnings miss and news that CEO Jim Rogers sold ...

Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook for long-term growth and profitability. The company uses AI to manage patient testing and help ...

Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest since its successful IPO in June 2024. The stock had been on a strong ...

Tempus AI held its IPO in June 2024 and is applying AI solutions to healthcare. Investors should watch several metrics to assess the company's growth prospects. While Tempus AI could reap big ...

But one ticker that may be less recognizable among the AI crowd is certainly off to a roaring start since the ball fell on New Year's Eve. Skyrocketing 108% since the start of 2025, Tempus AI ...

Shares of Tempus AI (NASDAQ:TEM) dropped 19% Tuesday, the day after the AI-focused healthcare company released a Q4 earnings report that missed Street estimates and its 2025 financial forecast.